Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines
US5997860A · kind A · utility
60Cited by
4References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 1995 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Nov 15, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally co-administered with a other colony stimulating factors (CSF), cytokines, lymphokines, interleukins, hematopoietic growth factors or IL-3 variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.